Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. This report aims to provide a comprehensive presentation of the global market for Gene Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery Systems. This report contains market size and forecasts of Gene Delivery Systems in global, including the following market information: Global Gene Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global Gene Delivery Systems market was valued at US$ 7282.5 million in 2022 and is projected to reach US$ 9845.7 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%. North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019. Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Gene Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ millions) Global Gene Delivery Systems Market Segment Percentages, by Type, 2022 (%) Viral Gene Delivery System Non-viral Gene Delivery System Combined Hybrid System Global Gene Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ millions) Global Gene Delivery Systems Market Segment Percentages, by Application, 2022 (%) Infectious Diseases Oncology Ophthalmology Urology Diabetes CNS Others Global Gene Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global Gene Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Gene Delivery Systems revenues in global market, 2018-2023 (estimated), ($ millions) Key companies Gene Delivery Systems revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Novartis Amgen Oxford BioMedica SIBIONO Shanghai Sunway Biotech Roche Pfizer Bayer Johnson & Johnson Becton Dickinson AstraZeneca Baxter HSCI Epeius Biotechnologies Outline of Major Chapters: Chapter 1: Introduces the definition of Gene Delivery Systems, market overview. Chapter 2: Global Gene Delivery Systems market size in revenue. Chapter 3: Detailed analysis of Gene Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Gene Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Gene Delivery Systems Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Gene Delivery Systems Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.
